Accessibility helpSkip to navigationSkip to contentSkip to footer

Cookies on FT Sites

We use cookies and other data for a number of reasons, such as keeping FT Sites reliable and secure, personalising content and ads, providing social media features and to analyse how our Sites are used.

Accept cookies
Manage cookies
  • Sign In
  • Subscribe
Open side navigation menuOpen search bar
Financial Times
SubscribeSign InmyFT
  • Home
  • World
    Sections
    • World Home
    • Global Economy
    • UK
    • US
    • China
    • Africa
    • Asia Pacific
    • Emerging Markets
    • Europe
    • War in Ukraine
    • Americas
    • Middle East & North Africa
    • Australia & NZ
    Most Read
    • Joe Biden warns China over threats to US sovereignty in State of the Union address
    • Zelenskyy speech spurs UK to look at sending fighter jets to Ukraine
    • Military briefing: what the west’s shifting red lines mean for Ukraine
    • UAE grants Russian lender rare banking licence
    • Erdoğan visits quake-hit area as Turkey-Syria death toll passes 11,000
  • UK
    Sections
    • UK Home
    • UK Business & Economy
    • UK Politics & Policy
    • Brexit
    • UK Companies
    • Personal Finance
    Most Read
    • Brussels demands answers after UK abruptly rejects residence for thousands of EU citizens
    • Treasury bans capital spending by Michael Gove’s Whitehall department
    • Britain set to resume payments for army’s troubled armoured vehicle programme
    • UK Supreme Court dismisses Northern Ireland protocol challenge
    • Boris Johnson has earned nearly £5mn since leaving office
  • Companies
    Sections
    • Companies Home
    • Energy
    • Financials
    • Health
    • Industrials
    • Media
    • Professional Services
    • Retail & Consumer
    • Tech Sector
    • Telecoms
    • Transport
    Most Read
    • Adani faced margin call on $1.1bn loan before repaying in full
    • ‘You can’t be half pregnant’: Why Rothschild is calling time on the public market
    • Credit Suisse plans $380mn bonus scheme for top staff tied to overhaul
    • Maersk forecasts plunge in profits as container shipping boom ends
    • Walt Disney to axe 7,000 jobs in $5.5bn cost-cutting plan
  • Tech
  • Markets
    Sections
    • Markets Home
    • Alphaville
    • Markets Data
    • Cryptofinance
    • Capital Markets
    • Commodities
    • Currencies
    • Equities
    • Fund Management
    • Trading
    • Moral Money
    • ETF Hub
    Most Read
    • Live news updates from February 8: UK mulls sending jets to Ukraine, Disney stems streaming losses
    • UK regulator deals blow to Microsoft’s $75bn Activision deal
    • Fall in petrol use in gas-guzzling US heralds shift for global markets
    • Equinor makes record $75bn profit during energy crisis
    • Iran’s ‘ghost fleet’ switches into Russian oil
  • Climate
  • Opinion
    Sections
    • Opinion Home
    • Columnists
    • The FT View
    • Lex
    • Obituaries
    • Letters
    Most Read
    • The revenge of the incumbents
    • Say no to oversized — choose clothes that fit
    • Lessons from the great reflation
    • Are CEOs with MBAs good for business?
    • Sunak is haunted by Tory ghosts and fantasies of cake
  • Work & Careers
    Sections
    • Work & Careers Home
    • Business School Rankings
    • Business Education
    • Entrepreneurship
    • Recruitment
    • Business Books
    • Business Travel
    Most Read
    • Barclays chief: the life lessons I have discovered during cancer treatment
    • Management research: why are so few of its ideas taken up?
  • Life & Arts
    Sections
    • Life & Arts Home
    • Arts
    • Books
    • Food & Drink
    • FT Magazine
    • House & Home
    • Style
    • Travel
    • FT Globetrotter
    Most Read
    • The Rijksmuseum’s Vermeer retrospective is momentous and dizzying
    • Inside Vermelho, Christian Louboutin’s new hotel
    • How to ski, shop, sled and sip it in St Moritz
    • Star gauze – Nensi Dojaka is redefining sexy dressing for the female gaze
    • Pirate Enlightenment by David Graeber — sea battles and radical social experiments
  • HTSI
MenuSearch
  • Home
  • World
  • UK
  • Companies
  • Tech
  • Markets
  • Climate
  • Opinion
  • Work & Careers
  • Life & Arts
  • HTSI
Financial Times
SubscribeSign In

Covid-19 vaccines

Add to myFT Digest

Add this topic to your myFT Digest for news straight to your inbox

  • Sunday, 29 January, 2023
    Drugs research
    RQ Bio partners with AstraZeneca in Covid antibody fight

    UK biotech racing to keep antibody up to date with latest variants

  • Tuesday, 10 January, 2023
    Chinese bank tries to entice wealthy customers with mRNA vaccines

    Hong Kong-based lender seeks to cater to mainlanders’ demand for western jabs

  • Monday, 9 January, 2023
    CureVac GmbH
    Covid vaccine makers CureVac and Novavax appoint new chiefs

    Pharmaceutical groups to part ways with longstanding executives

  • Monday, 9 January, 2023
    InterviewPharmaceuticals sector
    SK Bioscience says ‘national pride’ prevents China from accepting foreign Covid jabs

    South Korean vaccine maker looks elsewhere to expand overseas business

  • Friday, 6 January, 2023
    New Chinese mRNA Covid vaccine shows positive early results

    Jab developed by CanSinoBio could help nation grappling with a wave of infection

  • Thursday, 5 January, 2023
    ExplainerCoronavirus pandemic
    How serious is the threat of new Covid-19 variants?

    A surge in cases after China lifted restrictions has sparked concerns that a dangerous new strain could emerge

  • Tuesday, 3 January, 2023
    EU offers free Covid-19 vaccines to China to help curb outbreak

    Beijing rejects Brussels’ offer, citing full control of situation

  • Monday, 26 December, 2022
    Chinese society
    Chinese vaccine tourists flock to Macau for mRNA Covid jabs

    Explosion of cases and ban on more effective western shots lead residents to look abroad

  • Monday, 12 December, 2022
    China warned to accelerate approval of updated jabs to tackle Covid ‘tsunami’

    Authorities have relied on vaccines made using original strain found in Wuhan

  • Wednesday, 7 December, 2022
    Coronavirus pandemic
    China risks ‘wave of infections’ after relaxing zero-Covid policy, warns Fauci

    Joe Biden’s chief medical adviser urges Beijing to approve use of western vaccines

  • Tuesday, 6 December, 2022
    News in-depthChinese politics & policy
    China’s elderly vaccine refuseniks pose obstacle for Xi Jinping

    Nearly 90mn Chinese are insufficiently protected against Covid as Beijing begins to unwind pandemic controls

  • Monday, 5 December, 2022
    FIFA World Cup
    World Cup briefing: Final whistle blows for Qatar’s shortlived stadiums

    Plus, Japan look to make history, defensive Dutch plot different course

  • Thursday, 1 December, 2022
    US warns Beijing it cannot control Covid-19 without western jabs

    Joe Biden’s coronavirus tsar says Chinese vaccines are ‘not as good’ as alternatives

  • Tuesday, 29 November, 2022
    Medical science
    Epidemic coalition sets out plan to develop future vaccines in 100 days

    Cepi releases blueprint to move three times faster against a new virus than during Covid-19 pandemic

  • Friday, 25 November, 2022
    News in-depthChinese politics & policy
    ‘No way we can open’: China’s zero-Covid exit plans unravel

    Economic and social costs are climbing but Beijing has failed to offer a way out of endless lockdowns

  • Thursday, 10 November, 2022
    AstraZeneca PLC
    AstraZeneca drops submission to US regulators for Covid-19 vaccine approval

    Plan abandoned almost two years after initial approval in UK and Europe

  • Tuesday, 8 November, 2022
    Patent wars: Moderna’s battle for the spoils of Covid vaccines

    Ending of pharma group’s IP truce spells fight for future of mRNA technology

  • Monday, 7 November, 2022
    BioNTech
    Profits drop at BioNTech as Covid vaccine demand wanes

    Fall from €3.2bn in the third quarter of 2021 to €1.8bn

  • Thursday, 3 November, 2022
    Moderna
    Moderna cuts Covid vaccine sales forecast

    Jab maker ties weaker revenue outlook to delivery delays and manufacturing issues

  • Wednesday, 2 November, 2022
    Chinese equities
    Chinese stocks boosted by planned rollout of CanSino’s inhalable Covid vaccine

    Market rallies on hopes of looser coronavirus lockdown measures and travel restrictions

  • Tuesday, 1 November, 2022
    Pfizer Inc
    Pfizer lifts revenue outlook as Covid jab price rise boosts sales

    US drugmaker’s coronavirus vaccine has almost doubled in price since its launch in 2020

  • Monday, 24 October, 2022
    Richard Hatchett
    We must stop being one step behind whichever virus comes for us next

    This is how the world can get faster and smarter in its ability to respond to outbreaks of new infectious diseases

  • Monday, 24 October, 2022
    Seth Berkley
    Vaccine market failures will hinder us in next pandemic

    Lack of fair access is ‘one of the biggest chinks in our armour’

  • Tuesday, 18 October, 2022
    ReviewNon-Fiction
    The Long Shot — Kate Bingham on Britain’s Covid vaccine rollout

    The head of the UK’s vaccine procurement tells the inside story of the risks, criticism and political interference she faced

  • Sunday, 16 October, 2022
    Vaccine makers face revenue slump as demand falls for Covid jabs

    Pharmaceutical companies hunt for new revenue streams as coronavirus becomes endemic

Previous page You are on page 1 Next page

Recommended

Covid-19 vaccine tracker: Lowest-income countries lag further behind rest of the world
Covid vaccine development: The shots available and the doses administered
In graphics: the UK vaccine supply chain
Coronavirus: free to read
Coronavirus tracker: the latest figures as countries fight the Covid-19 resurgence

Be part of FT Community

Discover unmissable flagship events and members only communities to expand your thinking and elevate your career

FT LiveGlobal Pharma and Biotech SummitDriving Investment and Innovation in Life Sciences
Tuesday, 7th NovemberUK & Online
Learn more about FT Community

Useful links

Support

View Site TipsHelp CentreContact UsAbout UsAccessibilitymyFT TourCareers

Legal & Privacy

Terms & ConditionsPrivacy PolicyCookiesCopyrightSlavery Statement & Policies

Services

Share News Tips SecurelyIndividual SubscriptionsGroup SubscriptionsRepublishingExecutive Job SearchAdvertise with the FTFollow the FT on TwitterFT ChannelsSecondary Schools

Tools

PortfolioToday's Newspaper (ePaper)Alerts HubBusiness School RankingsEnterprise ToolsNews feedNewslettersCurrency Converter

Community & Events

FT CommunityFT Live EventsFT ForumsFT Board DirectorBoard Director Programme

More from the FT Group

Markets data delayed by at least 15 minutes. © THE FINANCIAL TIMES LTD 2023. FT and ‘Financial Times’ are trademarks of The Financial Times Ltd.
The Financial Times and its journalism are subject to a self-regulation regime under the FT Editorial Code of Practice.
Financial Times

UK Edition

Subscribe for full access
  • Switch to International Edition
  • Top sections
  • Home
  • World
    • Global Economy
    • UK
    • US
    • China
    • Africa
    • Asia Pacific
    • Emerging Markets
    • Europe
    • War in Ukraine
    • Americas
    • Middle East & North Africa
    • Australia & NZ
  • UK
    • UK Business & Economy
    • UK Politics & Policy
    • Brexit
    • UK Companies
    • Personal Finance
  • Companies
    • Energy
    • Financials
    • Health
    • Industrials
    • Media
    • Professional Services
    • Retail & Consumer
    • Tech Sector
    • Telecoms
    • Transport
  • Tech
  • Markets
    • Alphaville
    • Markets Data
    • Cryptofinance
    • Capital Markets
    • Commodities
    • Currencies
    • Equities
    • Fund Management
    • Trading
    • Moral Money
    • ETF Hub
  • Climate
  • Opinion
    • Columnists
    • The FT View
    • Lex
    • Obituaries
    • Letters
  • Work & Careers
    • Business School Rankings
    • Business Education
    • Entrepreneurship
    • Recruitment
    • Business Books
    • Business Travel
  • Life & Arts
    • Arts
    • Books
    • Food & Drink
    • FT Magazine
    • House & Home
    • Style
    • Travel
    • FT Globetrotter
  • Personal Finance
    • Property & Mortgages
    • Investments
    • Pensions
    • Tax
    • Banking & Savings
    • Advice & Comment
    • Next Act
  • HTSI
  • Special Reports
  • FT recommends
  • Lex
  • Alphaville
  • Lunch with the FT
  • FT Globetrotter
  • #techAsia
  • Moral Money
  • FTfm
  • Newsletters
  • Video
  • Podcasts
  • News feed
  • FT Live Events
  • FT Forums
  • Board Director Programme
  • myFT
  • Portfolio
  • Today's Newspaper (ePaper)
  • Crossword
  • Our Apps
  • Help Centre
  • Subscribe
  • Sign In